Press

What people are saying about Lokavant

This page is coming soon...

THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution
Mar 25, 2021, 09:00 ET

THREAD and Lokavant to deploy advanced clinical operations benchmarking solution to establish industry reference points for DCTs utilizing THREAD

Read More
Joint Study Shows Decentralized Clinical Trials More Resilient than Traditional Trials During Global Pandemic
Feb 11, 2021, 07:53 ET

THREAD-Supported DCTs Outperform Industry Benchmark in Patient Recruitment and Retention

Read More

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Read More
THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution
Mar 25, 2021, 09:00 ET

THREAD and Lokavant to deploy advanced clinical operations benchmarking solution to establish industry reference points for DCTs utilizing THREAD

Read More
Joint Study Shows Decentralized Clinical Trials More Resilient than Traditional Trials During Global Pandemic
Feb 11, 2021, 07:53 ET

THREAD-Supported DCTs Outperform Industry Benchmark in Patient Recruitment and Retention

Read More
Roivant Launches Lokavant to Provide Real-Time and Anticipatory Clinical Trial Monitoring
Jan 13, 2020, 07:00 ET

Lokavant has entered into multi-year enterprise license agreement with Parexel

Read More

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Read More

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Read More

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Read More